Emcure Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of change in email and website address of Registrar and Share Transfer Agent of the Company'.
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has informed the stock exchange about an update to the contact details of its Registrar and Share Transfer Agent (RTA). The change involves a new email address and website for the RTA, which handles shareholder-related services such as share transfers, demat requests, and dividend payments. This is a routine administrative disclosure filed by the company to comply with listing requirements. The change does not affect any shareholder's holdings, transactions, or rights in any way. Investors may simply note the updated contact details for future correspondence with the RTA.
This is a procedural, non-material update with no effect on the company's financials, business, or stock price. Shareholders should only take note if they plan to contact the RTA directly.